Identification | More | [Name]
Sitagliptin phosphate monohydrate | [CAS]
654671-77-9 | [Synonyms]
SITAGLIPTIN PHOSPHATE 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)Butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazinephosphatemonohydrate Sitagliptin phosphate monohydrate Sitagliptin phosphate for research | [EINECS(EC#)]
682-492-2 | [Molecular Formula]
C16H20F6N5O6P | [MDL Number]
MFCD10001393 | [Molecular Weight]
523.324 | [MOL File]
654671-77-9.mol |
Chemical Properties | Back Directory | [Fp ]
274.3℃ | [storage temp. ]
2-8°C | [solubility ]
≥23.8 mg/mL in DMSO; insoluble in EtOH; ≥30.6 mg/mL in H2O with ultrasonic | [form ]
solid | [color ]
White to off-white | [Optical Rotation]
-5.53°(C=0.60g/100mL, NAOH, 20°C, 589nm) | [InChIKey]
IQFYVLUXQXSJJN-OVMXBOEKNA-N | [SMILES]
P(O)(O)(O)=O.C(C1=NN=C2CN(C(=O)C[C@H](N)CC3C=C(F)C(F)=CC=3F)CCN12)(F)(F)F |&1:15,r| | [CAS DataBase Reference]
654671-77-9(CAS DataBase Reference) |
Hazard Information | Back Directory | [Chemical Properties]
white crystalline | [Uses]
antimuscarinic | [Biological Activity]
sitagliptin phosphate monohydrate is the phosphate salt of its active component, sitagliptin, with one molecule of water. sitagliptin is a potent inhibitor of dipeptidyl peptidase 4 (dpp-4), an enzyme catalyzing the cleavage of peptides with an n-terminal alanine or proline amino acid residue, that selectively inhibits dpp-4 with 50% inhibition concentration ic50 value of 18 nm and shows no affinity towards other ddp enzymes (such as ddp-8 and ddp-9). the inhibition of dpp4 by sitagliptin has been found to be mediated by increasing levels of two dpp-4 substrates, including glucagon-like peptide-1 (glp-1) and gastric inhibitory polypeptide (gip). sitagliptin is currently being investigated in the treatment of type ii diabetes.gallwitz b. review of sitagliptin phosphate: a novel treatment for type 2 diabetes. vasc health risk manag. 2007;3(2):203-10. | [Synthesis]
The general procedure for the synthesis of (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one as a raw material and its phosphate hydrate was carried out in the following manner: 8.14 g of (R)-3-amino-1-( 3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one, 16.3 mL of isopropanol, and 7.3 mL of water, followed by the slow dropwise addition of 1.73 mL of 85% (v/v) phosphoric acid aqueous solution. The temperature of the reaction system was raised to 80 °C until complete dissolution to form a clear solution. The solution was then cooled to 70 °C and the reaction was continuously stirred at this temperature for 2 hours. Upon completion of the reaction, the mixture was cooled to 54 °C at a rate of 8 °C/h and then continued to cool to 22 °C at a rate of 16 °C/h, at which point a large amount of white solid precipitated. 57 mL of isopropanol was added slowly over a period of 40 minutes and stirring was continued for 15 minutes after addition. The white solid was collected by diafiltration and washed twice with 40.7 mL of mixed isopropanol-water solvent (V/V=11:1). Finally, the product was dried under vacuum at 25 °C and -0.08 MPa for 5.5 h to give 10.22 g of white crystalline solid. The purity was 99.91% by HPLC, the moisture content was 3.54% and the molar yield was 97.7%. | [target]
DPP-4 | [storage]
Store at -20°C | [References]
[1] Patent: CN105175422, 2018, B. Location in patent: Paragraph 0070; 0077; 0080; 0083; 0086; 0089; 0092; 0095 [2] Synthetic Communications, 2013, vol. 43, # 24, p. 3281 - 3286 [3] Patent: WO2006/33848, 2006, A1. Location in patent: Page/Page column 14 [4] Patent: WO2005/30127, 2005, A2. Location in patent: Page/Page column 13 [5] Patent: US2013/158265, 2013, A1. Location in patent: Paragraph 0204 |
|
|